AMN Healthcare (AMN) Q1 Earnings and Revenues Beat Estimates

Published on 10 May 2024 on Zacks via Yahoo Finance

AMN Healthcare (AMN) Q1 Earnings and Revenues Beat Estimates

AMN Healthcare Services, Inc. AMN delivered adjusted earnings per share (EPS) of 97 cents in the first quarter of 2024, which declined 61% year over year. However, the figure surpassed the Zacks Consensus Estimate by 4.3%.

GAAP EPS for the quarter was 45 cents, reflecting a 77.7% plunge from the year-ago figure.

Revenues in Detail

Read the rest of the article

NYSE.AMN price evolution

NYSE.BSX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Boston Scientific Corporation (NYSE:BSX) Stock Is Going Strong But Fundamentals...

Boston Scientific's (NYSE:BSX) stock is up by a considerable 12% over the past three months....

Simply Wall St. · via Yahoo Finance 19 Jan 2025

M&A Synergies Drive BSX: Is it Worth Buying the Stock Now?

BSX Ahead of Moving Averages Too Going by the technical indicators, the stock is trading above it...

Zacks · via Yahoo Finance 15 Jan 2025

Inspire Medical Stock Falls Despite Solid Preliminary Q4 Revenues

INSP's revenue growth in the fourth quarter is likely to have been boosted by increased market...

Zacks · via Yahoo Finance 14 Jan 2025

RVTY Stock Falls Despite FDA Nod for Automated Testosterone Test

Revvity, Inc. RVTY announced the receipt of the FDA’s 510(k) clearance for EUROIMMUN’s automated...

Zacks · via Yahoo Finance 13 Jan 2025

Reasons to Retain The Cooper Companies Stock in Your Portfolio Now

COO benefits from strength in its business segments. Its acquisitions are likely to drive the top...

Zacks · via Yahoo Finance 10 Jan 2025

Here's Why You Should Retain HealthEquity Stock in Your Portfolio Now

Key Picks Some better-ranked stocks in the broader medical space are Cardinal Health, Inc. CAH,...

Zacks · via Yahoo Finance 10 Jan 2025

Truist maintains Boston Scientific buy rating, $110 target By Investing.com

On Wednesday, Truist Securities expressed a continued optimistic stance on Boston Scientific stoc...

Investing.com 9 Jan 2025

AngioDynamics Stock Up on Q2 Earnings Beat, Gross Margin Declines

AngioDynamics, Inc. ANGO reported an adjusted loss per share of 4 cents for second-quarter fiscal...

Zacks · via Yahoo Finance 9 Jan 2025

BSX Stock Rises Following Bolt Medical Acquisition Deal Announcement

Boston Scientific Corporation BSX recently entered into a definitive agreement to acquire Bolt...

Zacks · via Yahoo Finance 9 Jan 2025

Boston Scientific to Acquire Bolt Medical for $443 Million in Ex

Plans to buy Bolt Medical, Inc., a developer of intravascular lithotripsy equipment for treating...

Guru Focus 9 Jan 2025

News

AMN Healthcare (AMN) Q1 Earnings and Revenues Beat Estimates

NYSE.AMN price evolution

NYSE.BSX price evolution

Want to become a better investor?